对于C型肝炎病毒疫苗设计的自组装蛋白质纳米颗粒上的原生类可溶性E1E2糖蛋白异构体
Linling He1, Yi-Zong Lee1, Yi-Nan Zhang1
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Nature communications
|February 11, 2026
概括
开发一种C型肝炎病毒 (HCV) 疫苗是一项挑战. 这项研究使用冷EM设计了稳定的E1E2抗原,改善了抗体结合,为有效的HCV疫苗铺平了道路.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 型肝炎病毒 (HCV) 导致严重的全球性肝病.
- 开发有效的HCV疫苗受到制造稳定E1E2抗原的挑战的阻碍,该抗原模仿本地病毒结构.
研究的目的:
- 为了设计一种稳定,可溶性E1E2抗原用于C型肝炎病毒疫苗.
- 利用冷电子显微镜 (cryo-EM) 结构来指导抗原设计.
- 为了增强抗原免疫性,用于潜在的疫苗开发.
主要方法:
- 工程基因型1a H77 sE1E2通过切断茎和删除区域,然后用支架稳定.
- 使用冷EM和负染色EM (nsEM) 进行结构确定和表位图绘制.
- 在自我组装蛋白质纳米粒子 (SApNPs) 上显示精制的抗原,以提高免疫性.
主要成果:
- 工程设计的H77 sE1E2.Cut1+2支架显示出与原生类型的E1-E2关联,并与广泛中和抗体 (bNAb) 强烈结合.
- 一个特定的构造,HCV-1 sE1E2.Cut1+2.SPYΔN,在结构上和通过EM.
- 显示抗原的SApNP在临床前评估中显示了增强免疫性潜力.
结论:
- 已经建立了一个开发基于E1E2的C型肝炎病毒疫苗的框架.
- 工程设计的sE1E2抗原和纳米粒子显示系统显示出对推进HCV疫苗候选人的承诺.
- 结构洞察力和工程策略对于克服HCV疫苗开发障碍至关重要.
相关概念视频
Protein Complex Assembly
16.9K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.9K
Protein Complex Assembly
2.6K
2.6K
Vaccinations
51.9K
Overview
51.9K
Factors Affecting Solubility
37.3K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.3K
Solubility Equilibria
57.8K
Solubility equilibria are established when the dissolution and precipitation of a solute species occur at equal rates. These equilibria underlie many natural and technological processes, ranging from tooth decay to water purification. An understanding of the factors affecting compound solubility is, therefore, essential to the effective management of these processes. This section applies previously introduced equilibrium concepts and tools to systems involving dissolution and precipitation.
The...
The...
57.8K
Solubility of Ionic Compounds
68.3K
Solubility is the measure of the maximum amount of solute that can be dissolved in a given quantity of solvent at a given temperature and pressure. Solubility is usually measured in molarity (M) or moles per liter (mol/L). A compound is termed soluble if it dissolves in water.
68.3K


